Julie Carrera and colleagues found hundreds of contract manufacturing companies capable of producing dual use chemicals and biological agents. Almost all companies are located in countries where they are subject to strategic trade controls.
On 20 March 2017, some 30 French research institutions, civil society organisations and associations signed the "Charter for Participatory Science and Research" in the presence of Thierry Mandon, State Secretary for Higher Education and Research.
On 24-25 April 2017, SYNENERGENE organised a workshop on Mutual Learning in Synthetic Biology: POLICY IMPLICATIONS OF RRI in Brussels. The workshop offered a platform for exchange on experiences and perspectives from the SYNENERGENE project.
One of the issues frequently popping up in debates about synthetic biology (synbio) is the possibility of introducing new and yet unknown types of biological risks.
ETC Group has developed an online searchable database of 'GMO 2.0’ ingre-dients. The beta version of 'GMO 2.0 database’ was launched at Natural Products Expo West 2017 in California and is now openly available for general testing.
In May 2017 the Public Engagement Team from the University of Bristol will launch an International Online Dialogue designed to help surface the concerns and views of young people aged 11-25 on synthetic biolo
In March 2017, The European Academies Science Advisory Council (EASAC) published a report on "Genome editing: scientific opportunities, public interests and policy options in the European Union".
On Friday, December 9th 2016, a multimedia event for the general public titled "Synthetic biology: bioreality and biofiction" took place at the Faculty of Social Sciences in Ljubljana in the scope of the EU 7th Framework programme "SYNENERGENE: Responsible Research and Innovation in Synthetic Biology" project.
Notions of ‘Responsible Research and Innovation’ (RRI) or ‘Responsible Innovation’ have evolved over at least ten years, both in the EU and the US.
The last weekend of October 2016, I was at the Giant Jamboree in Boston, USA, to meet as many members of the iGEM community as possible and present them with a tool we developed for them in order to support the community for a respon
Doing It Together Science (DITOs) will implement many innovative participatory event formats across Europe focusing on the active involvement of citizens in two critical areas: the cutting edge topic of biodesign and the pressing area of envi
In the past years, there has been a growing interest within the art and design community to engage with life sciences—from growing biomaterials (i.e., make mycelium furniture) to designing genetic circuits (i.e., explore bacterial photography
On October 27-31 the international Genetic Engineering Machine competition (iGEM) welcomed 3,000 attendees to Boston for the Giant Jamboree, the annual gathering of students presenting their projects.
The SYNENERGENE Forum is a large public event which will discuss the promises and implications of synthetic biology from a societal perspective. This programme gives detailed information about the sessions, workshops and speakers and venues.
What is the future of biotechnology? How can we create an ecosystem that integrates traditional and non-traditional actors and bolsters innovation?
Synthetic biology (synbio) is a very young and still unconsolidated new emerging technology.
On 14-15 January 2016, the European Economic and Social Committee (EESC) hosted the joint final event of 4 European projects, all working with the concept of RRI.
TAB, the Office of Technology Assessment at the German Bundestag, has analysed the safety and security issues of synthetic biology as well as the involvement of societal stakeholders a
This article outlines the role of synthetic biology in current industrial biotechnology production platforms, and gives insights into possible further developments.
This transatlantic exchange of perspectives on bioeconomy notions was organised by KIT-ITAS and TU Darmstadt in collaboration with the Royal Flemish Academy of Belgium for Sciences and Arts and took place in Brussels at the Palace of the Academies on October 8 & 9, 2015. The workshop brought together European and U.S. experts from the fields of policymaking, industry and civil society organisations discussing different stakeholder perspectives on bioeconomic notions, expectations and future challenges.